Genprex, Inc.
Genprex is a gene therapy company focused on developing life-changing technologies for patients with cancer & diabetes.
Austin, United States
24 employees
Post-IPO Equity
Total: $89.40M
Biopharma, Biotechnology +1
General Information
Austin, United States
BounceWatch is an independent company data service, not affiliated with Genprex, Inc.. To contact Genprex, Inc., visit genprex.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Genprex, Inc. compare?
A PDF of Genprex, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Genprex, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biopharma
About Genprex, Inc.
Business keywords: gene therapy, cancer treatment, diabetes treatment, clinical-stage company, disease-fighting genes, innovative technology, drug candidates, pipeline development, collaborative partnerships
Funding Rounds & Investors (10)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $6.50M | - |
|
19 Mar 2024 |
| Post IPO Equity | $7.50M | - |
|
19 Jul 2023 |
| Post IPO Equity | $4.00M | 1 |
|
27 Feb 2023 |
| Post IPO Equity | $25.00M | - |
|
09 Feb 2021 |
| Post IPO Equity | $28.00M | - |
|
28 May 2020 |
| Post IPO Equity | $10.00M | - |
|
08 May 2018 |
| Venture Round | $800.00K | - |
|
01 Sep 2017 |
| Venture Round | $1.10M | 1 |
|
03 Nov 2016 |
| Venture Round | $2.00M | - |
|
30 Dec 2013 |
| Seed Round | $4.50M | - |
|
15 Aug 2010 |
Genprex, Inc. Alternatives & Competitors
View All Alternatives
We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...
A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...
Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for patients...
FAQ About Genprex, Inc.
Source: BounceWatch company record for Genprex, Inc., https://bouncewatch.com/company/genprex, updated 30 December 2024. When citing, please name BounceWatch and link this page.
